Dr. Hasan Imanli, MD

Dr. Imanli practices at Ellicott City Healthcare Center in Ellicott City, Maryland.

Dr. Imanli's NPI, 1205325628, was assigned on May 2, 2018. Dr. Imanli holds Maryland license D0090861.

Dr. Imanli's primary practice is Ellicott City Healthcare Center, at 3000 North Ridge Road, Ellicott City, MD 21043 in Howard County. The practice phone is (410) 461-7577.

Dr. Imanli's primary practice is Ellicott City Healthcare Center in Ellicott City, Maryland. The medical group on file is Symphony Medical Associates PA. Dmand AI also links Dr. Imanli to 2 more skilled nursing facilities, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Imanli practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Imanli's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Imanli is licensed in Maryland.

CMS data shows 4,076 Medicare services from Dr. Imanli across 6 procedure codes in 2024, for 318 Medicare patients. Medicare paid $299,014 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 318 Medicare patients who saw Dr. Imanli in 2024. The largest group is 65 to 74, with 103 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 65% are also on Medicaid. Their average risk score is 3.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Imanli's median patient age at 70, with 46% women.

In 2024, Dr. Imanli wrote 11,072 Medicare Part D claims for 284 patients. 73% of them were for generic drugs. CMS names the drug for 10,355 of them, across 164 drugs with 11 or more claims each, at $1,268,872 in total drug cost. In 2023, CMS named 7,969 claims across 142 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Imanli for performance year 2024, reported as part of a group. Dr. Imanli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Imanli, published from 2017 to 2022. The most frequent topics are Tachycardia, Ventricular and Catheter Ablation. Dr. Imanli has published most often in J Nucl Med. Dr. Imanli's most frequent co-authors are Stephen Ross Shorofsky, MD, Mohammed S. Abdulghani, MD and Wengen Chen, MD.

CMS Open Payments shows 7 general payments to Dr. Imanli from 6 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 94% of the total. Urovant Sciences Inc paid the most, $125.